Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
People on the Move
LabVantage Solutions Names Mikael Hagstroem as Chief Executive Officer
Life Sciences Times
-
March 25, 2021
0
Public Health
AstraZeneca Covid vax 76% effective in updated trial data
Life Sciences Times
-
March 25, 2021
0
Pharma
3 common antiviral drugs potentially effective against Covid
Life Sciences Times
-
March 25, 2021
0
Pharma
New compound offers hope for anti-Covid drug
Life Sciences Times
-
March 25, 2021
0
Pharma
New Data Show Foreign Reference Drug Pricing Proposals Would Reduce the Development of New Innovative Medicines in California by 88%
Life Sciences Times
-
March 24, 2021
0
Real Estate
PIDC and Ensemble/Mosaic Execute Navy Yard Development Agreement, Launching $2.5 Billion Development Plan
Life Sciences Times
-
March 24, 2021
0
Real Estate
Brandywine Realty Trust Open Life Science Incubator on 14-acre $3.5 billion Schuylkill Yards Innovation Neighborhood
Life Sciences Times
-
March 24, 2021
0
Public Health
Dassault Systèmes Simulates Airflow in Paris Hospital to Reduce Risks of COVID-19 Exposure
Life Sciences Times
-
March 23, 2021
0
Real Estate
White Oak Healthcare MOB REIT Acquires 7 Medical Office Buildings in 5 States
Life Sciences Times
-
March 23, 2021
0
Life Sciences
Dr. Marcia Eisenberg, Chief Scientific Officer of Labcorp Diagnostics, Named a Healthcare Businesswoman’s Association Luminary
Life Sciences Times
-
March 23, 2021
0
1
...
774
775
776
...
805
Page 775 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026